AN-3025

N/A

Report date: 2026/02/06 20:01:23

Base Information

Drug NameAN-3025
Drug Alias NameAnti-hTNFR2(Adlai Nortye Biopharma)AN-3025
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionTumor necrosis factor receptor superfamily member 1B antagonists
TargetsTumor necrosis factor receptor superfamily member 1B
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHangzhou Adlai Nortye Biopharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesXiamen Biotime Biotechnology Co LtdHangzhou Adlai Nortye Biopharma Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A